Suzetrigine for Pain Relief After Cesarean Delivery Without Opioids
Treatments studied
Part of Pain clinical trials.
This study tests whether a new pain medication called suzetrigine can help you recover comfortably after a cesarean delivery without needing strong opioid painkillers. You'll receive the study drug and complete follow-up check-ins for two weeks after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and having a scheduled or emergency cesarean delivery
- Your surgery will use spinal or epidural anesthesia (numbing medicine through your spine)
- Your surgeon will use a Pfannenstiel incision (horizontal cut near your bikini line)
- You can speak English or Spanish and complete remote check-ins for 14 days after surgery
- You do not have serious liver or kidney disease
- You are not taking certain medications that interact with suzetrigine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new painkiller called suzetrigine for post-surgery pain. It's designed for people whose medical records suggest they may have a higher chance of needing strong painkillers (opioids) long after surgery. We want to see if suzetrigine works better at preventing that.
This study tests an investigational pain medicine called suzetrigine to see how well it controls pain after total hip replacement surgery. It is for adults 18–80 who are having a first-time hip replacement and can receive spinal anesthesia.
This trial tests a new pain medication called suzetrigine to see how well it reduces pain after ureteroscopy, a common procedure for kidney stones. If you are having this surgery, you may be able to join and get a treatment that could help you manage pain with fewer side effects.
This study tests whether a nerve block in the lower belly wall (transversalis fascia plane block) or a medication injected into the spinal fluid (intrathecal dexmedetomidine) provides better pain relief for mothers having a planned cesarean section under spinal anesthesia.
This trial tests a new pain medication, suzetrigine, for people having breast surgery (not mastectomy) who are expected to have moderate pain. It checks if this drug works well compared to standard options.
This study tests whether a new pain medication called suzetrigine can reduce the need for opioids (strong painkillers) after vaginal pelvic reconstructive surgery. The goal is to manage post-surgery pain safely with fewer opioids.
Hear when a new Cesarean Delivery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.